Medicine and Dentistry
Diffuse Large B-Cell Lymphoma
100%
Patient
59%
B Cell
51%
microRNA 155
47%
microRNA
28%
Gene
27%
Drug
24%
International Prognostic Index
24%
Lymphoma
23%
Biological Marker
22%
Multiple Myeloma
22%
Spontaneous Remission
22%
Tissues
22%
Programmed Cell Death
22%
Protein Tyrosine Kinase
22%
Cancer
22%
Therapeutic Procedure
21%
Neoplasm
17%
Diagnosis
15%
CD20
13%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
10%
Analysis
10%
Malignant Neoplasm
9%
B Lymphocyte Receptor
9%
Cyclophosphamide
9%
Doxorubicin
7%
Proportional Hazards Model
7%
Evaluation Study
7%
Evolution
7%
Screening
6%
Personalized Medicine
6%
Biopsy
6%
Prednisone
5%
Biochemistry, Genetics and Molecular Biology
MicroRNA
49%
Gene Signature
48%
Exon
22%
Bone
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cisplatin
22%
Programmed Cell Death
22%
Bendamustine
22%
Doxorubicin
7%
Apoptosis
5%